BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23703878)

  • 21. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry.
    Beohar N; Kirtane AJ; Blackstone E; Waksman R; Holmes D; Minha S; Alli O; Suri RM; Svensson LG; Leon M; Kodali S
    JACC Cardiovasc Interv; 2016 Feb; 9(4):355-363. PubMed ID: 26803420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement.
    Blakeslee-Carter J; Dexter D; Mahoney P; Ahanchi S; Steerman S; Larion S; Cain B; Panneton JM
    Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion.
    Binder RK; Barbanti M; Ye J; Toggweiler S; Tan J; Freeman M; Cheung A; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2014 May; 83(6):E221-6. PubMed ID: 24402965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Spitzer SG; Wilbring M; Alexiou K; Stumpf J; Kappert U; Matschke K
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E52-8. PubMed ID: 26708225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement.
    Flaherty MP; Mohsen A; Moore JB; Bartoli CR; Schneibel E; Rawasia W; Williams ML; Grubb KJ; Hirsch GA
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):118-29. PubMed ID: 25204308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvaging lowermost deployment of an acurate device during transcatheter aortic valve replacement with balloon and lasso pull techniques.
    Corcione N; Biondi-Zoccai G; Giordano A
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):490-3. PubMed ID: 26424553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unilateral Access Is Safe and Facilitates Peripheral Bailout During Transfemoral-Approach Transcatheter Aortic Valve Replacement.
    Khubber S; Bazarbashi N; Mohananey D; Kadri A; Gad MM; Kaur M; Sammour YM; Lyden M; Ahuja KR; Verma B; Menon V; Mick SL; Reed GW; Puri R; Svensson L; Navia JL; Tuzcu EM; Krishnaswamy A; Kapadia SR
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2210-2220. PubMed ID: 31699379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The routine use of surgical exposure approach for trans-femoral implantation of the balloon expandable aortic prosthesis is associated to a low rate of vascular complications.
    DE LA Torre Hernandez JM; Moreno R; Lee DH; Garcia Del Blanco B; Sanmartin JC; Garcia Blas S; Serra Garcia V; Gaviria K; Garcia I; Zueco J
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):615-9. PubMed ID: 25673098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".
    Schäfer U; Ho Y; Frerker C; Schewel D; Sanchez-Quintana D; Schofer J; Bijuklic K; Meincke F; Thielsen T; Kreidel F; Kuck KH
    JACC Cardiovasc Interv; 2012 May; 5(5):477-486. PubMed ID: 22625184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation.
    Basir MB; Velez C; Fuller B; Wyman J; Paone G; Wang DD; Guerrero M; Greenbaum A; O'Neill W
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E166-71. PubMed ID: 26255796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications.
    Borz B; Durand E; Tron C; Godin M; Canville A; Hauville C; Cribier A; Eltchaninoff H
    Catheter Cardiovasc Interv; 2014 May; 83(6):E227-32. PubMed ID: 24403004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States.
    Lardizabal JA; O'Neill BP; Desai HV; Macon CJ; Rodriguez AP; Martinez CA; Alfonso CE; Bilsker MS; Carillo RG; Cohen MG; Heldman AW; O'Neill WW; Williams DB
    J Am Coll Cardiol; 2013 Jun; 61(23):2341-5. PubMed ID: 23583248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
    Lardizabal JA; Macon CJ; O'Neill BP; Desai H; Singh V; Martinez CA; Alfonso CE; Cohen MG; Heldman AW; O'Neill WW; Williams DB
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1226-30. PubMed ID: 25511236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfemoral aortic valve implantation new criteria to predict vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.
    Cohen MG; Singh V; Martinez CA; O'Neill BP; Alfonso CE; Martinezclark PO; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):987-93. PubMed ID: 23729031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.